Bayer Schering Pharma AG v. Sun Pharmaceutical Industries, Inc.
2:11-cv-00054
Overview
Parties
Defendant
Counter Claimant
Court & Judges
Court
District Court, D. Nevada (nvd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6987101
Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
|
Filed: 2000-07-19
Issued: 2006-01-17
|
Expired (Term Ended)
Expires: 2020-07-19
|
|
|
US5798338
Solid dosage forms that contain clathrates of 17α-ethinyl estradiol
|
Filed: 1995-07-10
Issued: 1998-08-25
|
Expired (Term Ended)
Expires: 2015-07-10
|
|
|
US6933395
PROCESSING FOR PRODUCING OF DROSPIRENONE (6β, 7β, 15β, 16β-DIMETHYLENE-3-OXO-17α-PREGN-4-EN-21, 17-CARBOLACTONE, DRSP) AS WELL AS 7α-(3-HYDOXY-1-PROPLY)-6β, 7β; 15β, 16β-DIMETHYLENE-5β-ANDROSTANE-3β, 5,17β-TRIOL(ZK 92836) AND 6β, 7β; 15β, 16β-DIMETHYLENE-5β-HYDROXY
|
Filed: 2000-08-18
Issued: 2005-08-23
|
Expired (Term Ended)
Expires: 2020-08-18
|
|
|
US6958326
Cyclodextrin-drospirenone inclusion complexes
|
Filed: 2001-12-20
Issued: 2005-10-25
|
Expired (Term Ended)
Expires: 2021-12-20
|
|
|
US7163931
Compositions of estrogen-cyclodextrin complexes
|
Filed: 2005-04-11
Issued: 2007-01-16
|
Expired (Term Ended)
Expires: 2022-03-03
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.